178 related articles for article (PubMed ID: 38334805)
1. A single-point mutation in the rubella virus E1 glycoprotein promotes rescue of recombinant vesicular stomatitis virus.
Das PK; Gonzalez PA; Jangra RK; Yin P; Kielian M
mBio; 2024 Mar; 15(3):e0237323. PubMed ID: 38334805
[TBL] [Abstract][Full Text] [Related]
2. Two Point Mutations in Old World Hantavirus Glycoproteins Afford the Generation of Highly Infectious Recombinant Vesicular Stomatitis Virus Vectors.
Slough MM; Chandran K; Jangra RK
mBio; 2019 Jan; 10(1):. PubMed ID: 30622188
[TBL] [Abstract][Full Text] [Related]
3. Rubella virus: first calcium-requiring viral fusion protein.
Dubé M; Rey FA; Kielian M
PLoS Pathog; 2014 Dec; 10(12):e1004530. PubMed ID: 25474548
[TBL] [Abstract][Full Text] [Related]
4. Calcium-Dependent Rubella Virus Fusion Occurs in Early Endosomes.
Dubé M; Etienne L; Fels M; Kielian M
J Virol; 2016 Jul; 90(14):6303-6313. PubMed ID: 27122589
[TBL] [Abstract][Full Text] [Related]
5. Establishment of replication-competent vesicular stomatitis virus recapitulating SADS-CoV entry.
Zhu Z; Han Y; Gong M; Sun B; Zhang R; Ding Q
J Virol; 2024 May; 98(5):e0195723. PubMed ID: 38557247
[TBL] [Abstract][Full Text] [Related]
6. Both Sphingomyelin and Cholesterol in the Host Cell Membrane Are Essential for Rubella Virus Entry.
Otsuki N; Sakata M; Saito K; Okamoto K; Mori Y; Hanada K; Takeda M
J Virol; 2018 Jan; 92(1):. PubMed ID: 29070689
[TBL] [Abstract][Full Text] [Related]
7. Membrane Sphingomyelin in Host Cells Is Essential for Nucleocapsid Penetration into the Cytoplasm after Hemifusion during Rubella Virus Entry.
Mori Y; Sakata M; Sakai S; Okamoto T; Nakatsu Y; Taguwa S; Otsuki N; Maeda Y; Hanada K; Matsuura Y; Takeda M
mBio; 2022 Dec; 13(6):e0169822. PubMed ID: 36346228
[TBL] [Abstract][Full Text] [Related]
8. Recombinant Isfahan Virus and Vesicular Stomatitis Virus Vaccine Vectors Provide Durable, Multivalent, Single-Dose Protection against Lethal Alphavirus Challenge.
Nasar F; Matassov D; Seymour RL; Latham T; Gorchakov RV; Nowak RM; Leal G; Hamm S; Eldridge JH; Tesh RB; Clarke DK; Weaver SC
J Virol; 2017 Apr; 91(8):. PubMed ID: 28148802
[TBL] [Abstract][Full Text] [Related]
9. A Surrogate Animal Model for Screening of Ebola and Marburg Glycoprotein-Targeting Drugs Using Pseudotyped Vesicular Stomatitis Viruses.
Saito T; Maruyama J; Nagata N; Isono M; Okuya K; Takadate Y; Kida Y; Miyamoto H; Mori-Kajihara A; Hattori T; Furuyama W; Ogawa S; Iida S; Takada A
Viruses; 2020 Aug; 12(9):. PubMed ID: 32842671
[TBL] [Abstract][Full Text] [Related]
10. Expression and characterization of rubella virus glycoprotein E1 in yeast cells.
Wen H; Wang Z
Intervirology; 2005; 48(5):321-8. PubMed ID: 15956800
[TBL] [Abstract][Full Text] [Related]
11. Targeting of a heterodimeric membrane protein complex to the Golgi: rubella virus E2 glycoprotein contains a transmembrane Golgi retention signal.
Hobman TC; Woodward L; Farquhar MG
Mol Biol Cell; 1995 Jan; 6(1):7-20. PubMed ID: 7749196
[TBL] [Abstract][Full Text] [Related]
12. Two Point Mutations in the Glycoprotein of SFTSV Enhance the Propagation Recombinant Vesicular Stomatitis Virus Vectors at Assembly Step.
Hu Q; Zhang Y; Jiang J; Zheng A
Viruses; 2023 Mar; 15(3):. PubMed ID: 36992507
[TBL] [Abstract][Full Text] [Related]
13. Rubella virus pseudotypes and a cell-cell fusion assay as tools for functional analysis of the rubella virus E2 and E1 envelope glycoproteins.
Claus C; Hofmann J; Überla K; Liebert UG
J Gen Virol; 2006 Oct; 87(Pt 10):3029-3037. PubMed ID: 16963762
[TBL] [Abstract][Full Text] [Related]
14. Generation of VSV pseudotypes using recombinant ΔG-VSV for studies on virus entry, identification of entry inhibitors, and immune responses to vaccines.
Whitt MA
J Virol Methods; 2010 Nov; 169(2):365-74. PubMed ID: 20709108
[TBL] [Abstract][Full Text] [Related]
15. A Recombinant VSV-Based Bivalent Vaccine Effectively Protects against Both SARS-CoV-2 and Influenza A Virus Infection.
Ao Z; Ouyang MJ; Olukitibi TA; Warner B; Vendramelli R; Truong T; Meilleur C; Zhang M; Kung S; Fowke KR; Kobasa D; Yao X
J Virol; 2022 Sep; 96(18):e0133722. PubMed ID: 36069551
[TBL] [Abstract][Full Text] [Related]
16. Recombinant vesicular stomatitis virus vaccine vectors expressing filovirus glycoproteins lack neurovirulence in nonhuman primates.
Mire CE; Miller AD; Carville A; Westmoreland SV; Geisbert JB; Mansfield KG; Feldmann H; Hensley LE; Geisbert TW
PLoS Negl Trop Dis; 2012; 6(3):e1567. PubMed ID: 22448291
[TBL] [Abstract][Full Text] [Related]
17. Vesicular Stomatitis Virus Chimeras Expressing the Oropouche Virus Glycoproteins Elicit Protective Immune Responses in Mice.
Stubbs SH; Cornejo Pontelli M; Mishra N; Zhou C; de Paula Souza J; Mendes Viana RM; Lipkin WI; Knipe DM; Arruda E; Whelan SPJ
mBio; 2021 Aug; 12(4):e0046321. PubMed ID: 34340542
[TBL] [Abstract][Full Text] [Related]
18. Monitoring Viral Entry in Real-Time Using a Luciferase Recombinant Vesicular Stomatitis Virus Producing SARS-CoV-2, EBOV, LASV, CHIKV, and VSV Glycoproteins.
Lay Mendoza MF; Acciani MD; Levit CN; Santa Maria C; Brindley MA
Viruses; 2020 Dec; 12(12):. PubMed ID: 33348746
[TBL] [Abstract][Full Text] [Related]
19. Formation of bovine viral diarrhea virus E1-E2 heterodimers is essential for virus entry and depends on charged residues in the transmembrane domains.
Ronecker S; Zimmer G; Herrler G; Greiser-Wilke I; Grummer B
J Gen Virol; 2008 Sep; 89(Pt 9):2114-2121. PubMed ID: 18753220
[TBL] [Abstract][Full Text] [Related]
20. An
Byrd EA; Kielian M
mBio; 2017 Nov; 8(6):. PubMed ID: 29114027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
